Stericycle, Inc. (NASDAQ:SRCL) – Research analysts at Jefferies Group dropped their FY2017 earnings estimates for shares of Stericycle in a research report issued on Friday. Jefferies Group analyst S. Dodge now anticipates that the business services provider will post earnings of $4.49 per share for the year, down from their prior estimate of $4.59. Jefferies Group currently has a “Buy” rating and a $108.00 target price on the stock. Jefferies Group also issued estimates for Stericycle’s Q4 2017 earnings at $1.15 EPS and FY2018 earnings at $4.50 EPS.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). The business had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. Stericycle had a positive return on equity of 13.93% and a negative net margin of 0.79%. The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.24 EPS.
COPYRIGHT VIOLATION WARNING: “Stericycle, Inc. (SRCL) Forecasted to Earn FY2017 Earnings of $4.49 Per Share” was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.chaffeybreeze.com/2017/11/14/stericycle-inc-srcl-forecasted-to-earn-fy2017-earnings-of-4-49-per-share-2.html.
SRCL has been the subject of a number of other research reports. Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. BidaskClub lowered shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Barclays PLC reaffirmed an “overweight” rating and issued a $100.00 price objective on shares of Stericycle in a research note on Wednesday, August 9th. William Blair reaffirmed an “ourperform” rating on shares of Stericycle in a research note on Thursday, September 14th. Finally, Royal Bank Of Canada decreased their price objective on shares of Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research note on Thursday, November 9th. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $77.17.
Stericycle (NASDAQ SRCL) opened at $64.06 on Monday. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a market cap of $5,465.57, a P/E ratio of 14.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.19. Stericycle has a 12-month low of $61.62 and a 12-month high of $88.00.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, October 30th. The shares were sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the sale, the director now owns 205,576 shares of the company’s stock, valued at approximately $14,497,219.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 3.30% of the company’s stock.
Large investors have recently modified their holdings of the business. Schroder Investment Management Group acquired a new stake in shares of Stericycle in the 2nd quarter valued at $80,497,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Stericycle in the 2nd quarter valued at $33,710,000. Strs Ohio lifted its stake in shares of Stericycle by 26,943.3% in the 2nd quarter. Strs Ohio now owns 328,306 shares of the business services provider’s stock valued at $25,056,000 after purchasing an additional 327,092 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Stericycle by 6.4% in the 2nd quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock valued at $413,139,000 after purchasing an additional 323,664 shares during the last quarter. Finally, Clarkston Capital Partners LLC lifted its stake in shares of Stericycle by 43.1% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,013,885 shares of the business services provider’s stock valued at $72,614,000 after purchasing an additional 305,441 shares during the last quarter. 94.19% of the stock is owned by institutional investors.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.